NASTECH PHARMACEUTICAL CO INC
10-K405/A, EX-27, 2001-01-12
PHARMACEUTICAL PREPARATIONS
Previous: NASTECH PHARMACEUTICAL CO INC, 10-K405/A, 2001-01-12
Next: NASTECH PHARMACEUTICAL CO INC, S-2/A, 2001-01-12



<TABLE> <S> <C>

<ARTICLE>                     5

<S>                           <C>
<PERIOD-TYPE>                 YEAR
<FISCAL-YEAR-END>                                            DEC-31-1999
<PERIOD-START>                                                JAN-1-1999
<PERIOD-END>                                                 DEC-31-1999
<CASH>                                                            10,652
<SECURITIES>                                                       3,986
<RECEIVABLES>                                                      1,036
<ALLOWANCES>                                                           0
<INVENTORY>                                                          279
<CURRENT-ASSETS>                                                  16,486
<PP&E>                                                             4,666
<DEPRECIATION>                                                       986
<TOTAL-ASSETS>                                                    20,199
<CURRENT-LIABILITIES>                                              3,574
<BONDS>                                                                0
<COMMON>                                                              38
                                                  0
                                                            0
<OTHER-SE>                                                        16,738
<TOTAL-LIABILITY-AND-EQUITY>                                      20,199
<SALES>                                                              325
<TOTAL-REVENUES>                                                   5,631
<CGS>                                                                268
<TOTAL-COSTS>                                                          0
<OTHER-EXPENSES>                                                  13,713
<LOSS-PROVISION>                                                       0
<INTEREST-EXPENSE>                                                     0
<INCOME-PRETAX>                                                  (8,350)
<INCOME-TAX>                                                           0
<INCOME-CONTINUING>                                                    0
<DISCONTINUED>                                                         0
<EXTRAORDINARY>                                                        0
<CHANGES>                                                              0
<NET-INCOME>                                                     (8,350)
<EPS-BASIC>                                                       (1.32)
<EPS-DILUTED>                                                     (1.32)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission